INTERNATIONAL PATENT: CHILDREN'S NATIONAL MEDICAL CENTER FILES APPLICATION FOR "TRAINED TUMOR SPECIFIC T-CELL FOR IMMUNOTHERAPY AND USES THEREOF"

GENEVA, Nov. 25 -- CHILDREN'S NATIONAL MEDICAL CENTER (111 Michigan Avenue, N.w.Washington, DC 20010) filed a patent application (PCT/US2025/029147) for "TRAINED TUMOR SPECIFIC T-CELL FOR IMMUNOTHERAPY AND USES THEREOF" on May 13, 2025. With publication no. WO/2025/240479, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SANDLER, Anthony (7020 Oak Forest LaneBethesda, MD 20817), WU, Xiaofang (9708 Delamere CourtRockville, MD 20850)

Abstract: The invention described herein provides autologous immune cells and uses thereof ...